Skip to main content
. 2021 Feb 23;71(704):e209–e218. doi: 10.3399/bjgp20X714089

Figure 2a.

Figure 2a.

Proportion of patients with at least one prescription/dispensing for a glucose-lowering medication in each year, according to class of medication.

DPP4 = dipeptidyl peptidase-4 inhibitor. GLP1 = glucagon-like peptide 1 receptor agonists. SGLT2 = sodium-glucose cotransporter 2 inhibitor.